Table 2 Physical dosimetric characteristics of SARP patients

Ipsilateral lung

V₅ (%)

48.26 (39.58–53.93)

51.23 (43.02–58.31)

39.58 (16.35–53.90)

V₁₀ (%)

38.21 (30.72–44.22)

41.37 (34.56–50.51)

30.72 (21.26–44.90)

V₁₅ (%)

33.36 (31.04–39.12)

32.64 (23.84–40.40)

36.05 (31.54–41.00)

V₂₀ (%)

30.81 (27.33–33.74)

32.34 (26.50–36.50)

29.27 (26.69–33.74)

V₃₀ (%)

22.64 (18.70–27.42)

28.30 (23.41–33.58)

20.36 (16.56–22.53)

Contralateral lung

V₅ (%)

24.89 (18.48–30.27)

28.31 (23.98–36.47)

15.06 (5.73–30.82)

V₁₀ (%)

16.04 (12.03–20.30)

17.97 (14.10–22.72)

14.19 (3.50–21.71)

V₁₅ (%)

12.01 (8.71–15.70)

11.49 (2.86–17.11)

14.13 (8.79–17.23)

V₂₀ (%)

8.78 (6.24–11.48)

7.92 (4.60–11.05)

9.82 (6.43–13.87)

V₃₀ (%)

4.48 (2.96–7.66)

7.56 (2.94–15.65)

3.54 (2.25–7.18)

Total lung

V₅ (%)

32.74 (26.94–39.08)

39.04 (31.62–43.80)

16.77 (8.741–35.70)

V₁₀ (%)

24.42 (21.06–29.18)

29.18 (23.06–32.78)

20.88 (12.74–25.06)

V₁₅ (%)

21.49 (18.15–25.78)

19.06 (15.35–26.60)

24.38 (18.42–27.74)

V₂₀ (%)

19.39 (16.19–21.81)

19.28 (14.21–25.80)

20.00 (14.90–21.81)

V₃₀ (%)

13.79 (11.67–16.58)

22.95 (15.61–28.90)

12.14 (9.29–13.38)

Mean total lung dose (cGy)

978.80 (728.80–1116.00)

1069.00 (947.50 − 1218.00)

713.40 (433.60–1113.00)

Mean heart dose (cGy)

690.70 (487.00–909.70)

855.50 (428.50–1776.00)

537.10 (384.50–866.70)

Heart volume (cm³)

589.60 (556.30–656.10)

567.70 (517.90–630.80)

629.30 (567.60–731.70)

Maximum spinal cord dose (cGy)

2021.00 (1494.00–2376.00)

2781.00 (2015.00–4095.00)

1526.00 (1363.00–2026.00)

PTV/LV

0.18 (0.17–0.21)

0.18 (0.15–0.21)

0.19 (0.17–0.23)

Segmentation model (routine segmentation/large segmentation)

52/14

24/7

28/7